Clinical Trials Directory

Trials / Completed

CompletedNCT00168584

Different Doses of Vitamin A and Childhood Morbidity and Mortality

Randomised Study of the Impact of Different Doses of Vitamin A on Childhood Morbidity and Mortality

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
5,400 (planned)
Sponsor
Bandim Health Project · Academic / Other
Sex
All
Age
6 Months – 5 Years
Healthy volunteers
Not accepted

Summary

Vitamin A supplementation reduces all-cause mortality. It is therefore given with oral polio vaccine in national campaigns. However, it is not clear which dose is optimal. The two studies that have investigated the impact of different doses of vitamin A have both found that a smaller dose was better than a large dose. We therefore investigated if a smaller dose given with oral polio vaccine gives equal or better effect.

Detailed description

Vitamin A supplementation (VAS) to children above 6 months of age reduces all-cause mortality with 23 %1 to 30 % in low-income countries. WHO recommends VAS at vaccination contacts. The currently recommended doses to be administered every 3-6 months are 100,000 IU for infants between 6 and 11 months of age and 200,000 IU for children 12 months and older. There is no clear evidence that a large dose is better than a small dose, the tendency being the opposite in the two studies of different doses of VAS that have been published so far. With the global effort to eradicate polio, national immunization days with oral polio vaccine (OPV) offer an additional opportunity to provide vitamin A. In Guinea-Bissau, a combined OPV and VAS campaign took place in November 2002. Given the uncertainty about the best dose of VAS, we aimed to examine whether the dose of vitamin A currently recommended by WHO or half this dose gives a better protection against childhood morbidity and mortality.

Conditions

Interventions

TypeNameDescription
DRUGVitamin A

Timeline

Start date
2002-11-01
Completion
2003-08-01
First posted
2005-09-15
Last updated
2005-09-15

Locations

1 site across 1 country: Guinea-Bissau

Source: ClinicalTrials.gov record NCT00168584. Inclusion in this directory is not an endorsement.